SG10201706208SA - Immunomodulatory Agent and Uses Therefor - Google Patents

Immunomodulatory Agent and Uses Therefor

Info

Publication number
SG10201706208SA
SG10201706208SA SG10201706208SA SG10201706208SA SG10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA SG 10201706208S A SG10201706208S A SG 10201706208SA
Authority
SG
Singapore
Prior art keywords
immunomodulatory agent
uses therefor
therefor
immunomodulatory
agent
Prior art date
Application number
SG10201706208SA
Other languages
English (en)
Inventor
Ranjeny Thomas
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012901189A external-priority patent/AU2012901189A0/en
Application filed by Univ Queensland filed Critical Univ Queensland
Publication of SG10201706208SA publication Critical patent/SG10201706208SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201706208SA 2012-03-23 2013-03-25 Immunomodulatory Agent and Uses Therefor SG10201706208SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2012901189A AU2012901189A0 (en) 2012-03-23 Immunomodulatory agents and uses therefor

Publications (1)

Publication Number Publication Date
SG10201706208SA true SG10201706208SA (en) 2017-08-30

Family

ID=49221713

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201706208SA SG10201706208SA (en) 2012-03-23 2013-03-25 Immunomodulatory Agent and Uses Therefor
SG11201405848UA SG11201405848UA (en) 2012-03-23 2013-03-25 Immunomodulatory agent and uses therefor

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201405848UA SG11201405848UA (en) 2012-03-23 2013-03-25 Immunomodulatory agent and uses therefor

Country Status (17)

Country Link
US (1) US20150216955A1 (ja)
EP (1) EP2827890B1 (ja)
JP (2) JP2015512371A (ja)
KR (1) KR20150010716A (ja)
CN (2) CN110404062A (ja)
AU (1) AU2013234815B2 (ja)
BR (1) BR112014023572A2 (ja)
CA (1) CA2868123A1 (ja)
CL (1) CL2014002522A1 (ja)
EA (1) EA201491748A1 (ja)
IL (1) IL234756A0 (ja)
MX (1) MX2014011488A (ja)
MY (1) MY172706A (ja)
NZ (1) NZ631340A (ja)
PH (1) PH12014502063A1 (ja)
SG (2) SG10201706208SA (ja)
WO (1) WO2013138871A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012082803A2 (en) 2010-12-13 2012-06-21 Cel-Sci Corporation Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof
WO2012162564A1 (en) 2011-05-25 2012-11-29 Cel-Sci Corporation Method for inducing an immune response and formulations thereof
US10179164B2 (en) 2011-05-25 2019-01-15 Cel-Sci Corporation Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
CN109771444A (zh) * 2019-04-03 2019-05-21 哈尔滨北极神生物工程有限公司 蜂胶氨糖人参皂甙复合胶囊及制备方法
US20220218806A1 (en) * 2019-05-11 2022-07-14 CRL-SCI Corporation Peptides and conjugates for treatment of arthritis
CN115515614A (zh) * 2020-02-06 2022-12-23 尤尼根公司 用于改进关节健康和治疗关节炎的包含山姜属和其它植物提取物的组合物
CN112675299B (zh) * 2021-01-06 2023-10-20 黑龙江省百洲生物工程有限公司 一种防控鹅星状病毒复合佐剂灭活疫苗的制备方法
WO2024057793A1 (ja) * 2022-09-13 2024-03-21 国立大学法人信州大学 癌転移を抑制するシトルリン化ペプチド
CN117085118A (zh) * 2023-08-22 2023-11-21 北京大学人民医院 一种瓜氨酸化ii型胶原多肽疫苗及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
WO1989012458A1 (en) 1988-06-14 1989-12-28 Cell Med, Inc. Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
US6106840A (en) 1988-06-23 2000-08-22 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
FI87028C (fi) 1989-12-22 1992-11-10 Nokia Mobile Phones Ltd Metod foer att reglera effekt hos en spaenningsstyrd effektfoerstaerkare och koppling foer anvaendning i metoden
US5139749A (en) 1990-06-22 1992-08-18 Tas, Inc. Fluidized calcining process
PT98990A (pt) 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
ZA935112B (en) 1992-07-17 1994-02-08 Smithkline Beecham Corp Rapamycin derivatives
US5234140A (en) 1992-07-28 1993-08-10 S. C. Johnson & Son, Inc. Re-useable aerosol container
US5817308A (en) 1994-02-14 1998-10-06 University Of Rochester Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
IL129547A (en) 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
WO1997035035A1 (en) 1996-03-20 1997-09-25 Charles Nicolette A method for identifying cytotoxic t-cell epitopes
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
WO1998002441A2 (en) 1996-07-12 1998-01-22 Ariad Pharmaceuticals, Inc. Non immunosuppressive antifungal rapalogs
ES2308821T3 (es) 1997-12-15 2008-12-01 Astellas Pharma Inc. Nuevos derivados de pirimidin-5-carboxamida.
EP1212331B1 (en) 1999-08-24 2004-04-21 Ariad Gene Therapeutics, Inc. 28-epirapalogs
PL358132A1 (en) * 2000-03-23 2004-08-09 Akzo Nobel N.V. Use of mia in immunotherapy
PL216224B1 (pl) 2002-02-01 2014-03-31 Ariad Pharmaceuticals Pochodne rapamycyny zawierające fosfor, kompozycja je zawierająca oraz ich zastosowanie
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
CA2421321A1 (en) * 2003-03-07 2004-09-07 London Health Sciences Centre Research Inc. Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis
US7160867B2 (en) 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
US7220755B2 (en) 2003-11-12 2007-05-22 Biosensors International Group, Ltd. 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
WO2014176604A1 (en) * 2013-04-26 2014-10-30 Cel-Sci Corporation Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
JP2010505883A (ja) * 2006-10-12 2010-02-25 ザ ユニバーシティー オブ クイーンズランド 免疫応答を調節するための組成物および方法
EP2254588B1 (en) 2008-03-14 2017-10-11 Cel-Sci Corporation Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
JPWO2009116246A1 (ja) 2008-03-17 2011-07-21 パナソニック株式会社 通信方法、通信システム、モバイルノード及びアクセスルータ
WO2010048388A1 (en) 2008-10-22 2010-04-29 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Immunoassays for citrullinated proteins
WO2010147898A2 (en) 2009-06-15 2010-12-23 Rigel Pharmaceuticals, Inc. Small molecule inhibitors of spleen tyrosine kinase (syk)
EP2968435B1 (en) * 2013-03-12 2019-01-30 Tel HaShomer Medical Research Infrastructure and Services Ltd. Synthetic peptides for the treatment of autoimmune diseases
BR112015022597A2 (pt) * 2013-03-13 2017-10-24 Cour Pharmaceuticals Dev Company partículas modificadoras da imunidade para o tratamento de inflamação

Also Published As

Publication number Publication date
MX2014011488A (es) 2015-05-11
BR112014023572A2 (pt) 2017-09-12
JP2019070034A (ja) 2019-05-09
NZ631340A (en) 2016-11-25
SG11201405848UA (en) 2014-10-30
AU2013234815B2 (en) 2017-06-22
PH12014502063A1 (en) 2014-12-10
JP2015512371A (ja) 2015-04-27
MY172706A (en) 2019-12-11
WO2013138871A1 (en) 2013-09-26
CL2014002522A1 (es) 2015-06-12
AU2013234815A1 (en) 2014-10-09
EP2827890B1 (en) 2019-08-28
US20150216955A1 (en) 2015-08-06
EA201491748A1 (ru) 2015-02-27
KR20150010716A (ko) 2015-01-28
CN104519907A (zh) 2015-04-15
CN110404062A (zh) 2019-11-05
CA2868123A1 (en) 2013-09-26
EP2827890A4 (en) 2015-11-25
IL234756A0 (en) 2014-11-30
EP2827890A1 (en) 2015-01-28

Similar Documents

Publication Publication Date Title
HK1199023A1 (en) Substituted benzothienylpyrrolotriazines and uses thereof
HK1202545A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
HK1200822A1 (en) Substituted dipyridylamines and uses thereof
IL237309A0 (en) Benzocyclooctyne compounds and uses thereof
EP2829480A4 (en) FEEDING AND COUNTERING DEVICE FOR MEDICINAL PRODUCTS
EP2827029A4 (en) SEALING ELEMENT AND SEAL STRUCTURE
EP2884135A4 (en) THERMOREGULATOR AND THERMOREGULATOR COMPONENT
HK1210949A1 (en) Combinations and uses thereof
IL234756A0 (en) A preparation for regulating the immune system and its uses
ZA201501124B (en) Trans-clomiphene formulations and uses thereof
GB201216649D0 (en) Agents and methods
AP2014007869A0 (en) Substituted phenylimidazopyrazoles and use thereof
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
GB201214729D0 (en) Communicating assembly and apparatus
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
SI2830587T1 (sl) Sestavek za zaščito in uravnoteženje kože
GB201210989D0 (en) Composition and device
EP2922862A4 (en) COMPLEX FORMING MODULATING ACTIVE SUBSTANCES AND USES THEREOF
AU2012901189A0 (en) Immunomodulatory agents and uses therefor
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
GB201222342D0 (en) Compounds and uses thereof